Browse > Article
http://dx.doi.org/10.3746/jkfn.2009.38.12.1815

Mineral Imbalance: Bone Decalcification and Soft Tissue Calcification  

Jeong, Dae-Won (Dept. of Microbiology, Laboratory of Metabolic Disease Control for Bone, College of Medicine, Yeungnam University)
Lim, Hyun-Sook (Dept. of Public Health Administration, Hanyang Women’s College)
Kang, Young-Hee (Dept. of Food and Nutrition and Korean Institute of Nutrition, Hallym University)
Publication Information
Journal of the Korean Society of Food Science and Nutrition / v.38, no.12, 2009 , pp. 1815-1819 More about this Journal
Abstract
Based on the soft and rigid extents, tissues are mainly divided into two groups in mammals, soft tissues including heart, lung, kidney and brain, and hard tissues including tendon, cartilage, teeth and bone. Among various tissues, bone, a dynamic rigid organ, is continuously remodeled by the opposing functional activity between bone formation by osteoblasts and bone destruction by osteoclasts. Bone protects the soft tissues and provides mineral reservoirs, which can supply the mineral needs of other soft tissues to normally maintain cellular function. While calcification in bone is an important action to fundamentally support the body and protect the soft tissues, calcification in soft tissues, including the heart, aorta, kidney, lung and spleen, results in severe organ damages, eventually causing sudden death. A growing body of evidence indicates that the osteoporotic patient who are aging, post-menopausal, diabetes and chronic kidney disease simultaneously represent a high clinical incidence of soft tissue calcification, illustrating a link between soft tissue calcification and bone decalcification (osteoporosis). This study will review what is currently known about the connection between bone decalcification and soft tissue calcification.
Keywords
mineral; bone; hard tissue decalcification; osteoporosis; soft tissue calcification;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Kao CF, Chuang CY, Chen CH, Kuo HC. 2008. Human pluripotent stem cells: current status and future perspectives. Chin J Physiol 51: 214-225
2 Yajima Y, Kawashima S. 2002. Calpain function in the differentiation of mesenchymal stem cells. Biol Chem 383: 757-764   DOI   ScienceOn
3 Mosekilde L. 2008. Primary hyperparathyroidism and the skeleton. Clin Endocrinol (Oxf) 69: 1-19   DOI   ScienceOn
4 Raggio CL, Boyan BD, Boskey AL. 1986. In vivo hydroxyapatite formation induced by lipids. J Bone Miner Res 1: 409-415   DOI
5 Janzen J, Vuong PN. 2001. Arterial calcifications: morphological aspects and their pathological implications. Z Kardiol 90 Suppl 3: 6-11   DOI
6 Shapiro IM, Golub EE, Kakuta S, Hazelgrove J, Havery J, Chance B, Frasca P. 1982. Initiation of endochondral calcification is related to changes in the redox state of hypertrophic chondrocytes. Science 217: 950-952   DOI
7 Vaananen HK, Laitala-Leinonen T. 2008. Osteoclast lineage and function. Arch Biochem Biophys 473: 132-138   DOI   ScienceOn
8 Suda T, Nakamura I, Jimi E, Takahashi N. 1997. Regulation of osteoclast function. J Bone Miner Res 12: 869-879   DOI   ScienceOn
9 Mundy GR. 2007. Osteoporosis and inflammation. Nutr Rev 65: S147-151   DOI   ScienceOn
10 Gartner L, Pearce CJ, Saifuddin A. 2009. The role of the plain radiograph in the characterization of soft tissue tumours. Skeletal Radiol 38: 549-558   DOI   ScienceOn
11 Schmid K, McSharry WO, Pameijer CH, Binette JP. 1980. Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta. Atherosclerosis 37: 199-210   DOI   ScienceOn
12 Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V. 2004. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 89: 4246-4253   DOI   ScienceOn
13 Persy V, D'Haese P. 2009. Vascular calcification and bone disease: the calcification paradox. Trends Mol Med 15: 405-416   DOI   ScienceOn
14 Walsh MC, Kim N, Kadono Y, Rho J, Lee SY, Lorenzo J, Choi Y. 2006. Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol 24: 33-63   DOI   ScienceOn
15 Teitelbaum SL. 2000. Bone resorption by osteoclasts. Science 289: 1504-1508   DOI   ScienceOn
16 Price PA, Faus SA, Williamson MK. 2001. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 21: 817-824   DOI   ScienceOn
17 Raisz LG. 1999. Physiology and pathophysiology of bone remodeling. Clin Chem 45: 1353-1358
18 Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M, Dobnig H. 2007. Vascular calcification and osteoporosis-from clinical observation towards molecular understanding. Osteoporos Int 18: 251-259   DOI   ScienceOn
19 Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS. 1998. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12: 1260-1268   DOI   ScienceOn
20 Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ. 1998. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339: 1972-1978   DOI   ScienceOn
21 Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH. 2006. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Free Radic Biol Med 40: 1483-1493   DOI   ScienceOn
22 Arnett TR. 2008. Extracellular pH regulates bone cell function. J Nutr 138: 415S-418S   DOI
23 Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423: 337-342   DOI   ScienceOn
24 Fukagawa M, Akizawa T. 2006. Calcium abnormalities of dialysis patients. J Bone Miner Metab 24: 160   DOI
25 Teitelbaum SL, Ross FP. 2003. Genetic regulation of osteoclast development and function. Nat Rev Genet 4: 638-649   DOI   ScienceOn
26 Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20: 345-357   DOI   ScienceOn
27 Roodman GD. 1996. Advances in bone biology: the osteoclast. Endocr Rev 17: 308-332
28 Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. 1997. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386: 78-81   DOI   ScienceOn
29 Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI. 1997. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45-51   DOI   ScienceOn
30 Yoshitake H, Rittling SR, Denhardt DT, Noda M. 1999. Osteopontin-deficient mice are resistant to ovariectomy- induced bone resorption. Proc Natl Acad Sci U S A 96: 8156-8160   DOI   ScienceOn
31 Liberman M, Bassi E, Martinatti MK, Lario FC, Wosniak J Jr, Pomerantzeff PM, Laurindo FR. 2008. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol 28: 463-470   DOI   ScienceOn